Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can an app improve life for metastatic breast cancer patients?

NCT ID NCT06505018

Symptom relief Sponsor: UNICANCER Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a digital platform called Cureety TechCare can improve quality of life and reduce hospitalizations for people with metastatic triple-negative breast cancer starting first-line treatment. Participants will regularly report symptoms through the platform, which alerts their medical team if problems arise. Researchers will compare their outcomes to those receiving standard care alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Cureety TechCare digital telemonitoring platform
What this could lead to
If successful, this could show that remote symptom tracking helps patients feel better and stay out of the hospital during cancer treatment.
What could go wrong
This is a non-drug intervention, so the benefit may be small. The platform relies on patients reporting symptoms, which may not always be accurate or lead to better outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 472 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2024

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Signed a written informed consent form prior to participate in the study. Note: In case of physical incapacitation, a trusted representative of their choice, which is not the Investigator or sponsor, can sign on the behalf of the patients * Patients ≥18 years of age. * Patient with histologically documented metastatic triple negative breast cancer (ER (Oestrogen receptor) and PR (Progesterone receptor) \<10%, Her2 negative status). * Life expectancy \> 6 months as per investigator estimate. * Patient initiating a marketed authorized first-line systemic treatment in the metastatic setting. * Eastern Cooperative Oncology Group (ECOG) performance status (PS) ≤2. * Patient having completed the EORTC QLQ-C30 and EORTC QLQ-BR45 at baseline (response to questions 29 and 30 of EORTC QLQ-C30 at baseline are mandatory) * Affiliated to the social security system or equivalent health insurance. * Patient able and willing to complete web-based self-reported questionnaires, from initiation of first-line treatment and for the duration of the study (over multiple treatment lines) * Patient has access to a computer, tablet, or smartphone connected to the Internet. Exclusion Criteria: * Participation in another clinical trial using telemonitoring. * Physical or psychological incapacity of the patient to use the digital telemonitoring Cureety Techcare, according to the investigator's discretion. * Patient deprived of their liberty or under protective custody or guardianship.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Metastatic triple-negative breast carcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

triple-negative breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Metastatic triple-negative breast carcinoma

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    51 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CARIO - Hopital Privé des Cotes d'Armor

    NOT_YET_RECRUITING

    Plérin, France

  • CH Annecy Genevois

    NOT_YET_RECRUITING

    Épagny, France

  • CH Aunay-Bayeux

    NOT_YET_RECRUITING

    Bayeux, France

  • CH Colmar

    NOT_YET_RECRUITING

    Colmar, France

  • CH de Cholet

    RECRUITING

    Cholet, France

  • CHI de Mont-de-Marsan et du Pays des Sources

    NOT_YET_RECRUITING

    Mont-de-Marsan, France

  • CHP Sainte-Marie

    NOT_YET_RECRUITING

    Osny, France

  • CHR Orleans

    NOT_YET_RECRUITING

    Orléans, France

  • CHU Grenoble Alpes

    NOT_YET_RECRUITING

    La Tronche, France

  • CHU de Nimes

    NOT_YET_RECRUITING

    Nîmes, France

  • CHU de Poitiers

    NOT_YET_RECRUITING

    Poitiers, France

  • CHU de Saint-Etienne

    NOT_YET_RECRUITING

    Saint-Etienne, France

  • CHU de Tours

    NOT_YET_RECRUITING

    Tours, France

  • CHU de la réunion

    NOT_YET_RECRUITING

    La Réunion, France

  • Centre Francois Baclesse

    NOT_YET_RECRUITING

    Caen, France

  • Centre Georges François Leclerc

    NOT_YET_RECRUITING

    Dijon, France

  • Centre Hospitalier Emile Roux

    NOT_YET_RECRUITING

    Le Puy-en-Velay, France

  • Centre Hospitalier Fleyriat

    NOT_YET_RECRUITING

    Bourg-en-Bresse, France

  • Centre Hospitalier Intercommunal de Fréjus Saint Raphael

    NOT_YET_RECRUITING

    Fréjus, France

  • Centre Hospitalier Le Mans

    NOT_YET_RECRUITING

    Le Mans, France

  • Centre Hospitalier Louis Pasteur

    NOT_YET_RECRUITING

    Le Coudray, France

  • Centre Hospitalier Simone Veil de Beauvais

    RECRUITING

    Beauvais, France

  • Centre Hospitalier d'Auxerre

    NOT_YET_RECRUITING

    Auxerre, France

  • Centre Leon Berard

    NOT_YET_RECRUITING

    Lyon, France

  • Centre de Cancérologie Privé de Caen Maurice Tubiana

    NOT_YET_RECRUITING

    Caen, France

  • Centre de Cancérologie du Grand Montpellier

    NOT_YET_RECRUITING

    Montpellier, France

  • Centre hospitalier de Carcasonne

    RECRUITING

    Carcassonne, France

  • Centre hospitalier de Pau

    RECRUITING

    Pau, France

  • Clinique Ambroise-Pare Hartmann

    NOT_YET_RECRUITING

    Neuilly-sur-Seine, France

  • Clinique Mathilde - Les Hôpitaux Privés Rouennais

    NOT_YET_RECRUITING

    Rouen, France

  • Clinique Sainte Clotilde

    NOT_YET_RECRUITING

    La Réunion, France

  • Clinique de la Sauvegarde

    NOT_YET_RECRUITING

    Lyon, France

  • Diaconesses Croix Saint-Simon Hospital Complex

    NOT_YET_RECRUITING

    Paris, France

  • GHBS Lorient

    NOT_YET_RECRUITING

    Lorient, France

  • Groupe Hospitalier Mutualiste de Grenoble

    NOT_YET_RECRUITING

    Grenoble, France

  • Groupe Hospitalier Public du Sud de l'Oise (GHPSO)

    NOT_YET_RECRUITING

    Creil, France

  • Groupe Hospitalier de La Rochelle-Ré-Aunis

    NOT_YET_RECRUITING

    La Rochelle, France

  • Hia Begin

    NOT_YET_RECRUITING

    Saint-Mandé, France

  • Hôpital Américain de PARIS

    NOT_YET_RECRUITING

    Neuilly-sur-Seine, France

  • Hôpital Privé Jean Mermoz

    NOT_YET_RECRUITING

    Lyon, France

  • Hôpital Privé du Confluent

    NOT_YET_RECRUITING

    Nantes, France

  • Hôpital Simone Veil de Blois

    NOT_YET_RECRUITING

    Blois, France

  • ICHF - Centre Pierre Curie

    NOT_YET_RECRUITING

    Beuvry, France

  • Institut Andrée Dutreix

    NOT_YET_RECRUITING

    Dunkirk, France

  • Institut Godinot

    NOT_YET_RECRUITING

    Reims, France

  • Institut Paoli Calmettes

    NOT_YET_RECRUITING

    Marseille, France

  • Institut de Cancérologie de Lorraine

    NOT_YET_RECRUITING

    Vandœuvre-lès-Nancy, France

  • Institut de Cancérologie des Hauts-de-France (ICHF)

    NOT_YET_RECRUITING

    Arras, France

  • Polyclinique bordeaux nord

    RECRUITING

    Bordeaux, France

  • Recherche Oncologie Clinqiue 37 (ROC 37)

    NOT_YET_RECRUITING

    Chambray-lès-Tours, France

  • Sainte Catherine - Institut du Cancer Avignon Provence

    RECRUITING

    Avignon, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.